Moderna (MRNA) Q3 Earnings and Revenues Surpass Estimates
Portfolio Pulse from
Moderna (MRNA) reported Q3 earnings of $0.03 per share, surpassing the Zacks Consensus Estimate of a loss of $1.89 per share. This marks an improvement from a loss of $1.39 per share a year ago.
November 07, 2024 | 2:00 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Moderna's Q3 earnings of $0.03 per share exceeded expectations, which were a loss of $1.89 per share. This is a significant improvement from the previous year's loss of $1.39 per share.
The positive earnings surprise and improvement from last year's loss are likely to boost investor confidence and drive the stock price up in the short term.
CONFIDENCE 95
IMPORTANCE 90
RELEVANCE 100